{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:22:09Z","timestamp":1769599329850,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Australian National Health and Medical Research Council project grant award","award":["525431"],"award-info":[{"award-number":["525431"]}]},{"name":"development grant award","award":["APP1000703"],"award-info":[{"award-number":["APP1000703"]}]},{"name":"Australian Centre for Hepatitis and HIV Virology EOI grant 2010\/12 (CR&RJ)"},{"name":"Bill and Melinda Gates Foundation GCE Phase I grant","award":["OPP1015149"],"award-info":[{"award-number":["OPP1015149"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.vaccine.2013.07.062","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T17:30:36Z","timestamp":1375810236000},"page":"4548-4555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8+ T cell avidity following HIV-1 recombinant pox viral vaccination"],"prefix":"10.1016","volume":"31","author":[{"given":"Danushka K.","family":"Wijesundara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Tscharke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charani","family":"Ranasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.07.062_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"troviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel","volume":"304","author":"Thompson","year":"2010","journal-title":"Journal of the American Medical Association"},{"issue":"10","key":"10.1016\/j.vaccine.2013.07.062_bib0010","first-page":"1","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"1","author":"McMichael","year":"2010","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/08892220050042846","article-title":"A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection AIDS Vaccine Evaluation Group","volume":"16","author":"McElrath","year":"2000","journal-title":"AIDS Research and Human Retroviruses"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0020","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1016\/j.vaccine.2008.09.016","article-title":"Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers","volume":"26","author":"Guimaraes-Walker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0025","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the step study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.vaccine.2013.07.062_bib0030","first-page":"4","article-title":"A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1","volume":"29","author":"Kelleher","year":"2006","journal-title":"AIDS"},{"issue":"26","key":"10.1016\/j.vaccine.2013.07.062_bib0035","first-page":"2","article-title":"EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone","volume":"316","author":"McCormack","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nm.2316","article-title":"Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial","volume":"17","author":"Rolland","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/icb.2010.118","article-title":"Human immunodeficiency virus-1 vaccine design: where do we go now?","volume":"89","author":"Wijesundara","year":"2011","journal-title":"Immunology & Cell Biology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0050","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"or control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover","volume":"204","author":"Almeida","year":"2007","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.062_bib0055","first-page":"3","article-title":"A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists","volume":"5","author":"Lyons","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0060","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.166.6.1747","article-title":"sion and function of CD8 in a murine T cell hybridoma","volume":"166","author":"Ratnofsky","year":"1997","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.062_bib0065","first-page":"4","article-title":"T cell adhesion molecules","volume":"258","author":"Bierer","year":"1988","journal-title":"FASEB Journal"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/90650","article-title":"onal avidity maturation of CD8+ T cells without selection of higher affinity TCR","volume":"2","author":"Slifka","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0075","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.4049\/jimmunol.166.3.1690","article-title":"High-avidity CTL. exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL","volume":"166","author":"Derby","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0080","series-title":"Gene Vaccines","first-page":"183","article-title":"Prime-boost vaccines: an overview","author":"Wijesundara","year":"2012"},{"issue":"14","key":"10.1016\/j.vaccine.2013.07.062_bib0085","first-page":"3","article-title":"CD8+ T cell efficacy in vaccination and disease","volume":"62","author":"Appay","year":"2008","journal-title":"Nature Medicine"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0090","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1128\/JVI.02535-06","article-title":"Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection","volume":"81","author":"Critchfield","year":"2007","journal-title":"Journal of Virology"},{"issue":"107","key":"10.1016\/j.vaccine.2013.07.062_bib0095","first-page":"1","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"478","author":"Betts","year":"2006","journal-title":"Blood"},{"issue":"85","key":"10.1016\/j.vaccine.2013.07.062_bib0100","first-page":"4","article-title":"High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control","volume":"933","author":"Berger","year":"2011","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0105","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1128\/jvi.70.10.7103-7107.1996","article-title":"Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo","volume":"70","author":"Sharma","year":"1996","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0110","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0115","doi-asserted-by":"crossref","first-page":"13020","DOI":"10.1073\/pnas.192251199","article-title":"A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte\/macrophage colony-stimulating factor and CD40L","volume":"99","author":"Ahlers","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0120","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2013.1","article-title":"Unique IL-13Ralpha2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8+ T-cell avidity and protective immunity","author":"Ranasinghe","year":"2013","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0125","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.4049\/jimmunol.178.4.2370","article-title":"l HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine\/granzyme B profiles","volume":"178","author":"Ranasinghe","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0130","doi-asserted-by":"crossref","first-page":"e55788","DOI":"10.1371\/journal.pone.0055788","article-title":"Reduced interleukin-4 receptor alpha expression on CD8+ T cells correlates with higher quality anti-viral immunity","volume":"8","author":"Wijesundara","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0135","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/eji.200838995","article-title":"Immunisation route-dependent expression of IL-4\/IL-13 can modulate HIV-specific CD8+ CTL avidity","volume":"39","author":"Ranasinghe","year":"2009","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0140","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1016\/j.vaccine.2006.04.023","article-title":"Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1","volume":"24","author":"Ranasinghe","year":"2006","journal-title":"Vaccine"},{"issue":"122","key":"10.1016\/j.vaccine.2013.07.062_bib0145","first-page":"7","article-title":"Dose-dependent modulation of CD8 and functional avidity as a result of peptide encounter","volume":"16","author":"Kroger","year":"2007","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.vaccine.2013.07.062_bib0150","first-page":"7","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"24","author":"Seder","year":"2008","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0155","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses","volume":"204","author":"Precopio","year":"2007","journal-title":"Journal of Experimental Medicine"},{"issue":"171","key":"10.1016\/j.vaccine.2013.07.062_bib0160","first-page":"6","article-title":"High avidity antigen-specific CTL identified by CD8-independent tetramer staining","volume":"511","author":"Choi","year":"2003","journal-title":"Journal of Immunology"},{"issue":"36","key":"10.1016\/j.vaccine.2013.07.062_bib0165","first-page":"1","article-title":"A correlation between function and selected measures of T cell avidity in influenza virus-specific CD8+ T cell responses","volume":"295","author":"La Gruta","year":"2006","journal-title":"European Journal of Immunology"},{"issue":"204","key":"10.1016\/j.vaccine.2013.07.062_bib0170","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1084\/jem.20062376","article-title":"Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation","author":"Xiao","year":"2007","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0175","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.174.4.2021","article-title":"Progressive differentiation and commitment of CD8+ T cells to a poorly cytolytic CD8low phenotype in the presence of IL-4","volume":"174","author":"Kienzle","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0180","doi-asserted-by":"crossref","first-page":"17475","DOI":"10.1073\/pnas.0809549105","article-title":"Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells","volume":"105","author":"Apte","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0185","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.4049\/jimmunol.178.11.7211","article-title":"A novel functional CTL avidity\/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian\/human immunodeficiency viral depletion of mucosal CD4+ T cells","volume":"178","author":"Belyakov","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.virol.2008.08.019","article-title":"Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization","volume":"381","author":"Belyakov","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0195","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/nm1201-1320","article-title":"Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques","volume":"7","author":"Belyakov","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0200","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood-2005-11-4374","article-title":"Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa","volume":"107","author":"Belyakov","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0205","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1016\/j.vaccine.2005.05.032","article-title":"Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3","volume":"23","author":"Kent","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0210","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1002\/eji.201141453","article-title":"Lack of IL-7 and IL-15 signaling affects interferon-gamma production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells","volume":"41","author":"Isakov","year":"2011","journal-title":"European Journal of Immunology"},{"issue":"101","key":"10.1016\/j.vaccine.2013.07.062_bib0215","first-page":"4","article-title":"IL-15\/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells","volume":"1515","author":"Oh","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"205","key":"10.1016\/j.vaccine.2013.07.062_bib0220","first-page":"3","article-title":"An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses","volume":"6","author":"Harari","year":"2008","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2567.2004.02070.x","article-title":"CD8 T cells require CD8 coreceptor engagement for calcium mobilization and proliferation, but not cytokine production","volume":"114","author":"Kerry","year":"2005","journal-title":"Immunology"},{"issue":"227","key":"10.1016\/j.vaccine.2013.07.062_bib0230","first-page":"8","article-title":"High avidity CD8+ T cells generated from CD28-deficient or wildtype mice exhibit a differential dependence on lipid raft integrity for activation","volume":"14","author":"Cawthon","year":"2004","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0235","doi-asserted-by":"crossref","first-page":"11432","DOI":"10.1073\/pnas.0504851102","article-title":"Contribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responses","volume":"102","author":"Kedzierska","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0240","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0091-6749(95)70326-8","article-title":"Elevation of IgE in HIV-infected children and its correlation with the progression of disease","volume":"95","author":"Vigano","year":"1995","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.062_bib0245","first-page":"8","article-title":"Role of IgE immune complexes in the regulation of HIV-1 replication and increased cell death of infected U1 monocytes: involvement of CD23\/Fc epsilon RII-mediated nitric oxide and cyclic AMP pathways","volume":"3","author":"Ouaaz","year":"1996","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.vaccine.2013.07.062_bib0250","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0952-7915(00)00153-9","article-title":"Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of epsilon germline transcripts","volume":"12","author":"Oettgen","year":"2000","journal-title":"Current Opinion in Immunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13010487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13010487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T15:37:37Z","timestamp":1731339457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13010487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":50,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0264410X13010487"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8+ T cell avidity following HIV-1 recombinant pox viral vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}